Competing Products. For the period commencing on the Effective Date and ending on [***], each of Takeda and Orexigen shall not, and shall ensure that their respective Affiliates and sublicensees do not, (whether directly or through a Third Party), commercialize in the Territory any pharmaceutical product, other than (a) the Products or (b) [***]. For the avoidance of doubt, this Section 8.4.5 shall apply to any Successor of either Party.
Appears in 3 contracts
Samples: Collaboration Agreement, Collaboration Agreement (Orexigen Therapeutics, Inc.), Collaboration Agreement
Competing Products. For the period commencing on the Original Effective Date and ending on […***…], each of Takeda and Orexigen shall not, and shall ensure that their respective Affiliates and sublicensees do not, (whether directly or through a Third Party), commercialize in the Territory any pharmaceutical product, other than (a) the Products or (b) […***…]. For the avoidance of doubt, this Section 8.4.5 shall apply to any Successor of either Party.
Appears in 1 contract
Samples: Collaboration Agreement (Orexigen Therapeutics, Inc.)
